- Riximyo® was listed on the PBS on 1 October 2019.
- Truxima® was listed on the PBS on 1 January 2020.
- Ruxience® was listed on the PBS on 1 June 2022.
These brands are listed under the Section 100 Highly Specialised Drugs Program and the Efficient Funding of Chemotherapy Program.
Biosimilar medicine fact sheet – rituximab
About this resource
Publication date:
Publication type:
Fact sheet
Audience:
General public
Language:
English
Part of a collection: